Federal Supply Schedule 36F79723D0136
Award Date
6/1/23
Last Date to Order
11/19/24
Federal Agency
Veterans Integrated Service Network 12
Awardee
Amylyx Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The key products and services being delivered under the federal contract IDV award to Amylyx Pharmaceuticals Inc. (doing business as Amylyx) are the procurement of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS), for the U.S. Department of Veterans Affairs (VA). Amylyx, a self-certified small disadvantaged business, has secured multiple contract vehicles with the VA to facilitate the distribution of its pharmaceutical products to veterans, including a Federal Supply...
The provided information describes a Blanket Purchase Agreement (BPA) contract vehicle awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Amylyx Pharmaceuticals Inc., a self-certified small disadvantaged business. The single-award BPA, valued at $50,000, enables VA facilities nationwide to order the pharmaceutical product RELYVRIO through June 2024. RELYVRIO, containing the active ingredients sodium phenylbutyrate and taurursodiol, is indicated for the...
The subject federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the National Acquisition Center, a division of the U.S. Department of Veterans Affairs (VA), to Amylyx Pharmaceuticals Inc. (Amylyx). The BPA, valued at $50,000, is for the procurement of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS) developed by Amylyx. As a self-certified small disadvantaged business, Amylyx has established several contract vehicles with the VA to facilitate the...
The Department of Veterans Affairs awarded a multiple-award federal supply schedule contract to Amryt Pharmaceuticals Inc. with a potential value of $225,000. The schedule is for pharmaceuticals and hematology-related products under contract number 65 IB. This enables ordering through September 2028. Additionally, the Department of Veterans Affairs National Acquisition Center awarded a single-award blanket purchase agreement to Amryt Pharmaceuticals with a value of up to $1,000,000. The BPA...
The U.S. Department of Veterans Affairs (VA) has awarded a $1.7M Federal Supply Schedule (FSS) contract to Amneal Pharmaceuticals of New York, LLC, a for-profit limited liability company that manufactures pharmaceutical products. The FSS contract, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, enables the VA to procure a variety of drugs, pharmaceuticals, and hematology-related products from Amneal through task orders over the 5-year contract period. Separately, the VA has also...
The Department of Veterans Affairs (VA) has awarded Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies, an IDV Federal Supply Schedule contract (36F79723D0194) valued at over $16.3 million. This multiple-award contract covers the procurement of drugs, pharmaceuticals, and hematology-related products through September 2028. Under this IDV, the VA Veterans Integrated Service Network 12 has issued firm fixed-price delivery orders for Acorda's Levodopa 42mg...
The Department of Veterans Affairs (VA) has awarded Amivas US LLC a five-year, $225,000 multiple-award Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB). This IDV allows VA medical facilities to issue task orders for Amivas' pharmaceuticals and hematology-related products. Amivas, a for-profit limited liability company, has prior experience providing pharmaceuticals and services related to clinical trials and medical research for federal agencies....
The U.S. Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) worth up to $2,500,000 to Amneal Pharmaceuticals of New York, LLC, a for-profit limited liability company that manufactures pharmaceutical products. The BPA is for the provision of the generic drug sodium oxybate, which is used to treat narcolepsy. Amneal Pharmaceuticals holds several indefinite delivery vehicle (IDV) contracts with federal agencies, including a 5-year, $1,700,000 Federal Supply...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded Lundbeck LLC a 5-year Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with a potential value of $124 million. Through this contract vehicle, the VA and other federal agencies can procure Lundbeck's portfolio of medications used to treat neurological conditions prevalent among veterans, including Sabril (vigabatrin) for treatment-resistant seizures, Xenazine (tetrabenazine) for chorea...
The provided information describes a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Catalyst Pharmaceuticals, Inc. The BPA, valued at $5,500,000, is placed against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of July 25, 2026. The primary purpose of this BPA is to enable the procurement of the pharmaceutical product Firdapse (amifampridine), an FDA-approved...